6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Vanguard Launches BondBuilder™ Model Portfolio Suite
Just now	Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
Just now	Summit State Bank Earns $1,674,000, or $0.25 Per Diluted Share, in First Quarter 2026
Just now	NetSuite Brings AI-Powered Speed and Precision to SuiteCloud Development
1m ago	BorgWarner Showcases Thermal, Power Electronics, Battery Solutions at Advanced Clean Transportation Expo 2026

About

Iovance Biotherapeutics Inc (NASDAQ:IOVA) — investor relations, events, news, and company updates on 6ix.

Latest News

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Updates on Tuesday, February 24, 2026

Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

Financials

Revenue

$263.5 M

Market Cap

$1.41 B

EPS

-1.09

Community Chat

Ask AI